Evidence map›Paper›PMID 11514605›Full record

ArticleThe Journal of experimental medicine2001

T cell development and T cell responses in mice with mutations affecting tyrosines 292 or 315 of the ZAP-70 protein tyrosine kinase.

A Magnan, V Di Bartolo, A M Mura, C Boyer, M Richelme, Y L Lin, A Roure, A Gillet, C Arrieumerlou, O Acuto and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 56 citations in OpenAlex.

  1. AFrontiers in immunology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. ZAP-70 in Signaling, Biology, and Disease.Annual review of immunology · 2018
    Review
  7. Intensity and duration of TCR signaling is limited by p38 phosphorylation of ZAP-70Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. ZAP70: a master regulator of adaptive immunity.Seminars in immunopathology · 2010
    Review
  15. ZAP-70: an essential kinase in T-cell signaling.Cold Spring Harbor perspectives in biology · 2010
    Review
  16. Stability of an autoinhibitory interface in the structure of the tyrosine kinase ZAP-70 impacts T cell receptor response.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  17. Review
  18. Article
  19. Review
  20. Allelic variant in CTLA4 alters T cell phosphorylation patterns.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

A MagnanCentre d'Immunologie de Marseille-Luminy, Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Univ.Med., Parc Scientifique de Luminy, 13288 Marseille Cedex 9, France.
V Di Bartolo
A M Mura
C Boyer
M Richelme
Y L Lin
A Roure
A Gillet
C Arrieumerlou
O Acuto
B Malissen
M Malissen
Inserm · FRCentre d’Immunologie de Marseille-Luminy · FRCentre National de la Recherche Scientifique · FRInstitut Pasteur · FRInstitut Cochin · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After stimulation of the T cell receptor (TCR), the tyrosine residues 292 and 315 in interdomain B of the protein tyrosine kinase ZAP-70 become phosphorylated and plausibly function as docking sites for Cbl and Vav1, respectively. The two latter proteins have been suggested to serve as substrates for ZAP-70 and to fine-tune its function. To address the role of these residues in T cell development and in the function of primary T cells, we have generated mice that express ZAP-70 molecules with Tyr to Phe substitution at position 292 (Y292F) or 315 (Y315F). When analyzed in a sensitized TCR transgenic background, the ZAP-70 Y315F mutation reduced the rate of positive selection and delayed the occurrence of negative selection. Furthermore, this mutation unexpectedly affected the constitutive levels of the CD3-zeta p21 phosphoisoform. Conversely, the ZAP-70 Y292F mutation upregulated proximal events in TCR signaling and allowed more T cells to produce interleukin 2 and interferon gamma in response to a given dose of antigen. The observation that ZAP-70 Y292F T cells have a slower rate of ligand-induced TCR downmodulation suggests that Y292 is likely involved in regulating the duration activated TCR reside at the cell surface. Furthermore, we showed that Y292 and Y315 are dispensable for the TCR-induced tyrosine phosphorylation of Cbl and Vav1, respectively. Therefore, other molecules present in the TCR signaling cassette act as additional adaptors for Cbl and Vav1. The present in vivo analyses extend previous data based on transformed T cell lines and suggest that residue Y292 plays a role in attenuation of TCR signaling, whereas residue Y315 enhances ZAP-70 function.

Indexed as

Point MutationAnimalsBase SequenceDNA PrimersMiceMice, Inbred C57BLMice, TransgenicPhosphorylationProtein-Tyrosine KinasesReceptors, Antigen, T-CellThymus GlandT-LymphocytesTyrosineZAP-70 Protein-Tyrosine KinaseDNA PrimersProtein-Tyrosine KinasesReceptors, Antigen, T-CellTyrosineZap70 protein, mouseZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID11514605
PMCPMC2193493
OpenAlexW2126450986

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.